Jessica Borrillo, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 700 Lemoyne Rd, Northwood, OH 43619 Phone: 419-691-3888 |
Shelby Strayer, M.A., CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Lemoyne Rd, Northwood, OH 43619 Phone: 419-691-3888 |
Mrs. Hannah Elizabeth Miedema, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 Lemoyne Rd, Northwood, OH 43619 Phone: 419-691-3888 |
News Archive
Bacterin International, Inc., a developer of revolutionary bone graft material, today announced a three-year agreement to provide its biologic line of products, OsteoSponge®, OsteoSelect®, OsteoSponge SC®, OsteoWrap®, BacFast®, and OsteoLock®, to the vast Broadlane® nationwide network of hospitals and medical practices.
Unigene Laboratories, Inc. today announced that the Company terminated its amended and restated exclusive worldwide license agreement and related development services and clinical supply agreement with GlaxoSmithKline (GSK) pertaining to an oral formulation of a recombinantly produced parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.
For overweight men ages 45 and older, the "High Five" factors of high cholesterol, high blood pressure, high blood sugar/glucose, poor diet and low testosterone may be impacting their energy and health, sabotaging efforts to lose weight, according to Building Healthier America, a national nonprofit organization dedicated to reversing the negative trends of overweight and obesity in the U.S.
Complete Genomics Inc., a third-generation human genome sequencing company, today announced that it has been selected as a 2009 Red Herring Global 100 award winner. The company was also recognized as a 2009 Red Herring North America 100 award winner earlier last year.
A new study has found that, contrary to current thinking, taking beta blockers that treat high blood pressure does not decrease a person's risk of developing colorectal cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also revealed that even long-term use or subtypes of beta blockers showed no reduction of colorectal cancer risk.
› Verified 5 days ago